Since 2019, COVID-19 has become a significant part of our lives. As we try to adjust to our new way of life, our knowledge surrounding covid-19 and how we must adapt and innovate as a company significantly grows. Science is...
Bedfont has seen a high demand for its NObreath® FeNO monitor following Rapid Uptake Products(RUP) programme Med-tech company, Bedfont, has seen a rise in demand for its NObreath® FeNO monitor, which aids in the diagnosis and monitoring of asthma, since...
Local company, Bedfont Scientific Ltd., fundraises and skydives to raise money for the Heart of Kent Hospice On Sunday 13th June, a group of Bedfont employees daringly jumped from a plane in a bid to raise £3000 for local charity,...
The Smoking Cessation & Health Conference UK (SCaH) is an annual dedicated event for professionals working in smoking cessation and related services in the UK that focuses on how to reduce the burden of smoking related death and disease. This...
Bedfont® presents its new Hydrogen and Methane Breath Testing Home Kits in association with GI Cognition With the pandemic of COVID-19 bringing a halt to most medical tests and procedures, it has highlighted a need to safely, easily, and remotely...
NHS Organisations can apply for funding from the Pathway Transformation Fund (PTF) to obtain a NObreath® used for asthma diagnosis and management. The NObreath® FeNO monitor from Bedfont® Scientific Ltd. has been included on the Rapid Uptake Products (RUPs) scheme...